PTHS 8-K: SEC filing

Filed with the SEC on · accession 0001919246-26-000134

PTHS filed a 8-K (current report) with the SEC on Nov 12, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Summary of the filing

Pelthos Therapeutics Inc. furnished a press release summarizing its financial results for the three and nine months ended September 30, 2026, along with an operational update.

Key details

RegistrantPelthos Therapeutics Inc.
Chief financial officer, treasurer and secretaryJohn M. Gay

✦ Ask GOAX AI about this filing — what it means for PTHS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PTHS?

Click here

Frequently asked questions

What did PTHS file with the SEC on Nov 12, 2026?

PTHS filed a 8-K (SEC filing). Pelthos Therapeutics Inc. furnished a press release summarizing its financial results for the three and nine months ended September 30, 2026, along with an operational update.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other PTHS SEC filings

Get alerts when PTHS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days